Is the experimental treatment exclusion used appropriately?
Priester
R
R
D003362:Cost-Benefit Analysis; D019317:Evidence-Based Medicine; D006801:Humans; D007348:Insurance, Health; D008910:Minnesota; D013812:Therapeutics / Q000191:economics* / Q000592:standards*; D014481:United States